Skip to content
Company Analysis

NewGenIvf Group Limited Warrant NIVFW

A comprehensive view of key metrics, scores, and financial health for NewGenIvf Group Limited Warrant

Overview of NewGenIvf Group Limited

NIVFW NCM
Healthcare Medical Care Facilities Framework: General Corporate
NewGenIvf Group Limited (NIVFW), in the Medical Care Facilities industry, last closed at $0.02, about 0.0% overvalued vs fair value, ranked 967/1145 in sector.
Metrics Rev Growth -13.0% ROE 77.2% Gross Margin 20.2%
USD 0.02
0.00%
(Delayed)
• Vol 90d: 234.2%
52-Week Range
Enterprise Value
-
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Weak
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Weak
Completeness: 68%
Confidence: 74%
Updated: Jul 5
Top Beats

Quick Facts

Website https://www.nivf.global
HQ Bangkok
Employees 76
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$4.7M
-13%%
Gross Profit
$955.8K
-47.7%%
Operating Income
$-10.7M
-824.3%%
Net Income
$9.9M
1983.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio FY2025
-168.8%
Poor

Operating Cash Flow / Net Income

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
0/1
Improving
0
High Impact
1
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating NewGenIvf Group Limited Warrant's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
24
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
15
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 85% Coverage
Trade-Off Triangle Visualization A ternary plot showing NIVFW's balance between Growth (14.0%), Profitability (39.3%), and Safety (46.7%). Growth 14% Safety 47% Profitability 39%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

15th percentile vs peers
16
Key Signals
Revenue CAGR 3Y -7.4% 18p Rev Growth YoY -13.0% 13p
Strengths
  • Interest Coverage Ratio in top 20% of peers (16.78, 84th percentile)
  • EBIT Margin in top 20% of peers (2.19, 99th percentile)
  • Net Profit Margin in top 20% of peers (2.09, 99th percentile)
  • Quick Ratio in top 20% of peers (2.98, 85th percentile)
  • Consistently strong margins across 3 metrics
Risks
  • Growth in bottom 20% of peers (percentile: 15)
  • Rev Growth YoY in bottom 20% of peers (-13.0%)

Profitability

44th percentile vs peers
45
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

53th percentile vs peers
53
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for NewGenIvf Group Limited Warrant.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000